PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
IYZ vs. SBIO
Performance
Return for Risk
Drawdowns
Volatility
Dividends

IYZ vs. SBIO

Last updated Jun 9, 2026

IYZ (iShares U.S. Telecommunications ETF) and SBIO (ALPS Medical Breakthroughs ETF) are both exchange-traded funds - IYZ is a Communications Equities fund tracking the Dow Jones U.S. Select Telecommunications Index, while SBIO is a Health & Biotech Equities fund tracking the S-Network Medical Breakthroughs Index. Both are passively managed. Over the past 10 years, IYZ returned 5.76%/yr vs 8.36%/yr for SBIO. At a 0.45 correlation, their price movements are largely independent. IYZ charges 0.42%/yr vs 0.50%/yr for SBIO.

Performance

IYZ vs. SBIO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in iShares U.S. Telecommunications ETF (IYZ) and ALPS Medical Breakthroughs ETF (SBIO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IYZ achieves a 26.58% return, which is significantly higher than SBIO's -1.72% return. Over the past 10 years, IYZ has underperformed SBIO with an annualized return of 5.76%, while SBIO has yielded a comparatively higher 8.36% annualized return.

IYZ

1D
0.40%
1M
3.16%
YTD
26.58%
6M
29.19%
1Y
51.92%
3Y*
28.42%
5Y*
7.24%
10Y*
5.76%

SBIO

1D
-0.36%
1M
-9.33%
YTD
-1.72%
6M
-2.48%
1Y
59.38%
3Y*
16.69%
5Y*
1.33%
10Y*
8.36%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IYZ vs. SBIO - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
IYZ
iShares U.S. Telecommunications ETF		26.58%29.28%20.53%3.90%-30.29%11.69%4.13%16.14%-8.59%-11.86%
SBIO
ALPS Medical Breakthroughs ETF		-1.72%55.07%3.81%8.68%-28.08%-17.55%21.17%50.30%-11.81%45.67%

Correlation

The correlation between IYZ and SBIO is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.

Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.31

Correlation (3Y)
Calculated over the trailing 3-year period

0.40

Correlation (5Y)
Calculated over the trailing 5-year period

0.48

Correlation (10Y)
Calculated over the trailing 10-year period

0.46

Correlation (All Time)
Calculated using the full available price history since Jan 2, 2015

0.45

The correlation between IYZ and SBIO shifts across timeframes, from 0.31 (1 year) to 0.48 (5 years), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

iShares U.S. Telecommunications ETF

ALPS Medical Breakthroughs ETF

Often compared with IYZ:
IYZ vs. XTLIYZ vs. VOXIYZ vs. XLCIYZ vs. IXPIYZ vs. IYRIYZ vs. FBMPXIYZ vs. SPY
Often compared with SBIO:
SBIO vs. XBISBIO vs. BBPSBIO vs. GERMSBIO vs. BBCSBIO vs. IBBSBIO vs. IBBQSBIO vs. PBE

Return for Risk

IYZ vs. SBIO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
IYZ
IYZ Risk / Return Rank: 9191
Overall Rank
IYZ Sharpe Ratio Rank: 9191
Sharpe Ratio Rank
IYZ Sortino Ratio Rank: 8989
Sortino Ratio Rank
IYZ Omega Ratio Rank: 8888
Omega Ratio Rank
IYZ Calmar Ratio Rank: 9595
Calmar Ratio Rank
IYZ Martin Ratio Rank: 9494
Martin Ratio Rank
SBIO
SBIO Risk / Return Rank: 7373
Overall Rank
SBIO Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
SBIO Sortino Ratio Rank: 7070
Sortino Ratio Rank
SBIO Omega Ratio Rank: 6060
Omega Ratio Rank
SBIO Calmar Ratio Rank: 8888
Calmar Ratio Rank
SBIO Martin Ratio Rank: 7878
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IYZ vs. SBIO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Telecommunications ETF (IYZ) and ALPS Medical Breakthroughs ETF (SBIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

IYZSBIODifference
Sharpe ratioReturn per unit of total volatility
2.84
2.02

+0.82

Sortino ratioReturn per unit of downside risk
3.75
2.85

+0.90

Omega ratioGain probability vs. loss probability

1.50

1.33

+0.17

Calmar ratioReturn relative to maximum drawdown

7.11

4.72

+2.40

Martin ratioReturn relative to average drawdown

26.20

13.54

+12.66

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

IYZ vs. SBIO - Sharpe Ratio Comparison

The current IYZ Sharpe Ratio is 2.84, which is higher than the SBIO Sharpe Ratio of 2.02. The chart below compares the historical Sharpe Ratios of IYZ and SBIO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Loading charts...

Sharpe Ratios by Period

IYZSBIODifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.84

2.02

+0.82

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.39

0.04

+0.35

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.30

0.25

+0.05

Sharpe Ratio (All Time)

Calculated using the full available price history

0.07

0.21

-0.14

Drawdowns

IYZ vs. SBIO - Drawdown Comparison

The maximum IYZ drawdown since its inception was -77.11%, which is greater than SBIO's maximum drawdown of -63.06%. Use the drawdown chart below to compare losses from any high point for IYZ and SBIO.

Loading charts...

Drawdown Indicators

IYZSBIODifference

Max Drawdown

Largest peak-to-trough decline

-77.11%

-63.06%

-14.05%

Max Drawdown (1Y)

Largest decline over 1 year

-7.33%

-12.66%

+5.33%

Max Drawdown (3Y)

Largest decline over 3 years

-13.85%

-42.44%

+28.59%

Max Drawdown (5Y)

Largest decline over 5 years

-39.74%

-53.10%

+13.36%

Max Drawdown (10Y)

Largest decline over 10 years

-39.74%

-63.06%

+23.32%

Current Drawdown

Current decline from peak

-6.96%

-17.90%

+10.94%

Average Drawdown

Average peak-to-trough decline

-40.13%

-28.43%

-11.70%

Ulcer Index

Depth and duration of drawdowns from previous peaks

1.99%

4.40%

-2.41%

Volatility

IYZ vs. SBIO - Volatility Comparison

The current volatility for iShares U.S. Telecommunications ETF (IYZ) is 8.23%, while ALPS Medical Breakthroughs ETF (SBIO) has a volatility of 9.87%. This indicates that IYZ experiences smaller price fluctuations and is considered to be less risky than SBIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading charts...

Volatility by Period

IYZSBIODifference

Volatility (1M)

Calculated over the trailing 1-month period

8.23%

9.87%

-1.64%

Volatility (6M)

Calculated over the trailing 6-month period

15.34%

22.68%

-7.34%

Volatility (1Y)

Calculated over the trailing 1-year period

18.43%

29.62%

-11.19%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.84%

33.56%

-14.72%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

19.29%

33.18%

-13.89%

IYZ vs. SBIO - Expense Ratio Comparison

IYZ has a 0.42% expense ratio, which is lower than SBIO's 0.50% expense ratio.

Dividends

IYZ vs. SBIO - Dividend Comparison

IYZ's dividend yield for the trailing twelve months is around 1.57%, while SBIO has not paid dividends to shareholders.

PositionTTM20252024202320222021202020192018201720162015
IYZ
iShares U.S. Telecommunications ETF		1.57%2.04%1.94%2.27%2.55%2.51%2.60%2.36%2.15%3.54%2.27%1.98%
SBIO
ALPS Medical Breakthroughs ETF		0.00%0.00%3.55%0.22%0.00%0.00%0.00%0.04%2.79%1.77%0.00%0.00%

Frequently Asked Questions

IYZ and SBIO have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

SBIO has higher volatility (9.87%) compared to IYZ (8.23%). In terms of maximum drawdown, IYZ dropped -77.11% vs SBIO's -63.06%.

On 10-year performance, SBIO leads with 8.36% vs 5.76% for IYZ. On fees, IYZ is cheaper at 0.42% per year. On volatility, IYZ has been the lower-risk option at 8.23%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, SBIO has performed better with a 8.36% return vs 5.76%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IYZ is cheaper with a 0.42% expense ratio, compared with 0.50% for SBIO.

IYZ has the higher dividend yield at 1.57%, compared with 0.00% for SBIO.

IYZ is categorized as Communications Equities, while SBIO is Health & Biotech Equities. IYZ tracks Dow Jones U.S. Select Telecommunications Index, while SBIO tracks S-Network Medical Breakthroughs Index. They also come from different issuers: iShares and SS&C. Their fees differ too: 0.42% for IYZ and 0.50% for SBIO.

IYZ currently has the higher Sharpe Ratio (2.84 vs 2.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IYZ and SBIO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer